NCT02910778View on ClinicalTrials.gov

The Effect of Ticagrelor With or Without Atorvastatin on Endothelial Function in Healthy Males

PHASE4CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

February 28, 2017

Study Completion Date

March 31, 2017

Conditions
Ischemia
Interventions
DRUG

Atorvastatin

Subjects will receive 80 mg atorvastatin once daily for 14 days (until study day 15). On study day 15, 80 mg atorvastatin in combination with a loading dose of 180 mg ticagrelor will be administered.

DRUG

Placebo

Subjects will receive placebo once daily for 14 days (until study day 15). On study day 15, placebo in combination with a loading dose of 180 mg ticagrelor will be administered.

DRUG

Ticagrelor

Trial Locations (1)

1090

Medical University of Vienna, Department of Clinical Pharmacology, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER

NCT02910778 - The Effect of Ticagrelor With or Without Atorvastatin on Endothelial Function in Healthy Males | Biotech Hunter | Biotech Hunter